Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

bioAffinity Technologies, Inc. (BIAF) had Revenue of $9.36M for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$9.36M
Net Income	$-9.04M
Cost of Goods Sold	$5.98M
Gross Profit	$3.38M
Operating Expenses	$18.32M
Operating Income	$-8.95M
Non-Operating Income/Expense	$-0.07M
Pre-Tax Income	$-9.03M
Normalized Pre-Tax Income	$-9.03M
Income after Taxes	$-9.04M
Income from Continuous Operations	$-9.04M
Consolidated Net Income/Loss	$-9.04M
Normalized Income after Taxes	$-9.04M
EBIT	$-8.95M
EBITDA	$-8.35M
Weighted-Average Shares Outstanding (Basic)	12.12M
Weighted-Average Shares Outstanding (Diluted)	12.12M
Earnings per Share (EPS) (Basic)	$-0.75
Earnings per Share (EPS) (Diluted)	$-0.75
Balance Sheet Financials
Current Assets	$2.70M
Property, Plant, and Equipment	$0.38M
Long-Term Assets	$3.82M
Total Assets	$6.51M
Current Liabilities	$3.10M
Long-Term Debt	$0.46M
Long-Term Liabilities	$0.81M
Total Liabilities	$3.91M
Common Equity	$2.60M
Tangible Shareholders Equity	$0.42M
Shareholders Equity	$2.60M
Common Shares Outstanding	15.58M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-7.26M
Cash Flow from Investing Activities	$-0.08M
Cash Flow from Financial Activities	$5.63M
Beginning Cash	$2.82M
End Cash	$1.11M
Increase/Decrease in Cash	$-1.72M
Stock-Based Compensation	$0.99M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.87
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.15
Debt to Equity Ratio	0.40
Gross Margin	36.09%
Operating Margin	-95.64%
EBIT Margin	-95.64%
EBITDA Margin	-89.17%
Pre-Tax Profit Margin	-96.43%
Profit Margin	-96.56%
Free Cash Flow	$-7.34M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	1.44
Inventory Turnover	216.73
Receiveable Turnover	8.22
Days Sales in Receivables	44.41
Return on Equity	-347.41%
Return on Tangible Equity	-2140.06%
Return on Assets	-138.78%
Return on Investments	-294.78%
Book Value Per Share	$0.17
Free Cash Flow per Share	$-0.61
Operating Cash Flow per Share	$-0.60

Data from Zacks Investment Research, Inc.